Opaleye Management Inc. 13D and 13G filings for Harrow Health, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 4:05 pm Purchase | 2023-12-31 | 13G | Harrow Health, Inc. HROW | Opaleye Management Inc. | 3,820,000 10.880% | 45,000 (+1.19%) | Filing |
| 2023-01-20 4:59 pm Purchase | 2022-12-31 | 13G | Harrow Health, Inc. HROW | Opaleye Management Inc. | 3,775,000 12.820% | 490,000 (+14.92%) | Filing |
| 2022-01-25 9:43 pm Purchase | 2021-12-31 | 13G | Harrow Health, Inc. HROW | Opaleye Management Inc. | 3,285,000 12.200% | 219,584 (+7.16%) | Filing |
| 2021-02-12 5:20 pm Purchase | 2020-12-31 | 13G | Harrow Health, Inc. HROW | Opaleye Management Inc. | 3,065,416 11.910% | 3,065,416 (New Position) | Filing |